Approval · Notice of Compliance 28031 · 2022
SUPEMTEK: Notice of Compliance 28031
Issued April 19, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28031
- Date
- April 19, 2022
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPEMTEK | Not yet assigned | — |
Medicinal ingredients
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A(H1N1) 45 MCG per 0.5ML
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A(H3N2) 45 MCG per 0.5ML
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (YAMAGATA) 45 MCG per 0.5ML
- RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (VICTORIA) 45 MCG per 0.5ML